Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000246578

Medchemexpress LLC 7-((4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide | 1012054-59-9 | MFCD15528940 | >98.0% | 434.49 g/mol | C24H26N4O4 | 50 MG
SDP

Catalog No. 5000246578
Encompass_Preferred

CUDC-101 is a small-molecule research inhibitor of histone deacetylases (HDACs), epidermal growth factor receptor (EGFR), and HER2, used in preclinical cancer research to assess antiproliferative and target-specific effects.

  • Potent inhibitor of HDAC, EGFR, and HER2 with low-nanomolar activity.
  • Demonstrates broad antiproliferative effects across cancer cell lines.
  • Supplied as a light yellow to yellow powder for laboratory use.
  • High purity suitable for research applications (reported ≥98% by HPLC).
  • Available in small-mass packaging for research workflows.
  • Molecular weight 434.49 g/mol.

Catalog No. 50-002-46578 Supplier Medchemexpress LLC Supplier No. HY1022350MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

CUDC-101 is a small-molecule research inhibitor of histone deacetylases (HDACs), epidermal growth factor receptor (EGFR), and HER2, used in preclinical cancer research to assess antiproliferative and target-specific effects.

  • Potent inhibitor of HDAC, EGFR, and HER2 with low-nanomolar activity.
  • Demonstrates broad antiproliferative effects across cancer cell lines.
  • Supplied as a light yellow to yellow powder for laboratory use.
  • High purity suitable for research applications (reported ≥98% by HPLC).
  • Available in small-mass packaging for research workflows.
  • Molecular weight 434.49 g/mol.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.